Article
Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
BMC research notes - 5 Jun 2023
Gunawardena Kawmadi, Sirisena Nirmala D, Anandagoda Gayani, Neththikumara Nilaksha, Dissanayake Vajira H W
Abstract excerpt
BACKGROUND: Next-Generation Sequencing (NGS)-based testing in cancer patients has led to increased detection of variants of uncertain significance (VUS). VUS are genetic variants whose impact on protein function is unknown. VUS pose a challenge to clinicians and patients due to uncertainty regarding their cancer predisposition risk. Paucity of data exists on the pattern of VUS in under-represented populations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
